Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS
比较 BCR-ABL1 阳性骨髓增生性肿瘤 (MPN) 急变期、原发性急性髓系白血病 (AML) 和继发于骨髓增生异常综合征 (MDS) 的 AML 患者接受造血干细胞移植 (HCT) 的疗效。
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2020002621
Gupta, Vikas; Kim, Soyoung; Hu, Zhen-Huan; Liu, Ying; Aljurf, Mahmoud; Bacher, Ulrike; Beitinjaneh, Amer; Cahn, Jean-Yves; Cerny, Jan; Copelan, Edward; Gadalla, Shahinaz M; Gale, Robert Peter; Ganguly, Siddhartha; George, Biju; Gerds, Aaron T; Gergis, Usama; Hamilton, Betty K; Hashmi, Shahrukh; Hildebrandt, Gerhard C; Kamble, Rammurti T; Kindwall-Keller, Tamila; Lazarus, Hillard M; Liesveld, Jane L; Litzow, Mark; Maziarz, Richard T; Nishihori, Taiga; Olsson, Richard F; Rizzieri, David; Savani, Bipin N; Seo, Sachiko; Solh, Melhem; Szer, Jeff; Verdonck, Leo F; Wirk, Baldeep; Woolfrey, Ann; Yared, Jean A; Alyea, Edwin P; Popat, Uday R; Sobecks, Ronald M; Scott, Bart L; Nakamura, Ryotaro; Saber, Wael
肿瘤
肿瘤免疫
细胞生物学
ABL1
白血病
干细胞
BCR
发育与干细胞